| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Kenneth Pienta last filed a Form 4 in March 2022, as Chief Medical Officer at CUE. Kenneth Pienta's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 2,000 shares of CUE. The CUE filings lean toward selling, a net 28,993 shares.
Kenneth Pienta has 11 Form 4 filings on record from January 2015 to March 2022, across 2 companies: Chief Medical Officer at Cue Biopharma (CUE), 2017–2022; Director at Curis (CRIS), 2015–2017.
The 18 reported transactions were 7 option or other derivative awards, 5 option exercises, 4 open-market sales and 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $56K and 2 sales worth about $510K.
The largest open-market purchase was 2,720 shares of CUE at an average $15.07 on January 20, 2021, about $41K.
The largest open-market sale was 20,274 shares of CUE at an average $15.13 on February 17, 2021, about $307K.
Shares as reported in the last Form 4 for each company; the most recent is from March 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2021 | CUE Cue Biopharma, Inc. | Chief Medical Officer | Sale+OE | 13,439 | $15.10 | $202,894.45 | -87.0% | -8.2% | -68.9% | |
| Feb 17, 2021 | CUE Cue Biopharma, Inc. | Chief Medical Officer | Sale+OE | 20,274 | $15.13 | $306,767.47 | -91.0% | - | - | |
| Jan 20, 2021 | CUE Cue Biopharma, Inc. | Chief Medical Officer | Buy | 2,720 | $15.07 | $40,979.52 | +136.0% | - | - | |
| Dec 27, 2017 | CUE Cue Biopharma, Inc. | Chief Medical Officer | Buy | 2,000 | $7.50 | $15,000.00 | New | - | - |